The HPV vaccine is one of the most important tools available to protect against serious diseases caused by human papillomavirus, commonly known as HPV. In the UK, the NHS recommends the HPV vaccine for children aged 12 to 13 and for people who are at higher risk of HPV infection. By preventing HPV, the vaccine helps reduce the risk of several cancers and other health conditions later in life.
This comprehensive guide explains what HPV is, how the HPV vaccine works, who should receive it, where to get it, possible side effects, and why screening is still important after vaccination. All information is based on official NHS guidance.
Human papillomavirus is a very common virus spread through close skin contact. This usually happens during sexual activity, but penetration is not required for transmission. Most people will come into contact with HPV at some point in their lives.
In many cases, HPV causes no symptoms and clears up without treatment. However, some types of HPV can persist in the body and lead to serious health problems, including cancer and genital warts.
| HPV-related condition | Description |
|---|---|
| Cervical cancer | One of the most common cancers linked to high-risk HPV types |
| Mouth and throat cancer | Can affect the tongue, tonsils, and throat |
| Anal cancer | Higher risk in certain groups, including men who have sex with men |
| Penile cancer | Rare but linked to persistent HPV infection |
| Vulval and vaginal cancer | Associated with high-risk HPV strains |
| Genital warts | Caused by low-risk HPV types |
Because HPV often has no symptoms, vaccination is a key way to reduce the risk of these conditions developing later.
The HPV vaccine helps protect against the most harmful types of HPV. In the UK, the NHS uses one vaccine called Gardasil 9. This vaccine protects against nine types of HPV, including those most commonly linked to cancer and genital warts.
The vaccine works by training the immune system to recognise HPV so the body can fight the virus if exposed in the future.
| Protection area | Benefit |
|---|---|
| High-risk HPV types | Reduces risk of multiple cancers |
| Low-risk HPV types | Prevents most cases of genital warts |
| Long-term health | Lowers cancer rates across the population |
Since the HPV vaccination programme began, there has been a significant reduction in HPV infections and HPV-related diseases in the UK.
The NHS recommends the HPV vaccine for several groups based on age and risk level.
Children in school year 8 are routinely offered the HPV vaccine through school vaccination programmes. This age is ideal because the vaccine is most effective when given before exposure to HPV.
Some young people may have missed the vaccine at school. The NHS offers catch-up vaccination to eligible individuals.
| Group | Eligibility |
|---|---|
| Girls aged 24 and under | If they missed vaccination at age 12 or 13 |
| Boys aged 24 and under | If born after 1 September 2006 and missed vaccination |
These individuals can usually arrange vaccination through their GP surgery, school nurse, or local vaccination team.
Men aged 45 and under who have sex with men are offered the HPV vaccine due to a higher risk of HPV-related cancers and genital warts. Vaccination is typically available through sexual health clinics or HIV clinics.
Some individuals may be considered at higher risk of HPV infection due to personal health factors. Healthcare professionals can advise whether vaccination is appropriate.
Most people who are eligible can safely receive the HPV vaccine. However, you should not have the vaccine if you have previously had a serious allergic reaction, known as anaphylaxis, to a dose of the vaccine or one of its ingredients.
There is no evidence that the HPV vaccine is harmful during pregnancy, but some people may be advised to delay vaccination until after pregnancy as a precaution. The vaccine is safe to receive while breastfeeding.
If you are unwell with a high temperature or feel too unwell to carry out normal activities, it is recommended to wait until you are feeling better before having the vaccine.
The HPV vaccine used in the UK is Gardasil 9. Full ingredient details are available in the official patient information leaflet published by the Electronic Medicines Compendium.
If you have allergies or concerns about ingredients, you should discuss these with a healthcare professional before vaccination.
The location where you receive the HPV vaccine depends on your age and eligibility.
| Who should have it | Where to get it |
|---|---|
| Children aged 12 to 13 | Secondary schools or community clinics |
| Girls aged 24 and under who missed vaccination | GP surgery, school nurse, vaccination team |
| Boys aged 24 and under who missed vaccination | GP surgery, school nurse, vaccination team |
| Men who have sex with men and others at higher risk | Sexual health clinics or HIV clinics |
The HPV vaccine is given as an injection into the upper arm. The number of doses required depends on age and immune system health.
| Age or health status | Number of doses | Schedule |
|---|---|---|
| Under 25 | 1 dose | Single injection |
| Aged 25 to 45 | 2 doses | 6 months to 2 years apart |
| Weakened immune system | 3 doses | Over a 12-month period |
Your healthcare provider will confirm the correct schedule for you.
Most side effects of the HPV vaccine are mild and short-term.
| Side effect | How common |
|---|---|
| Pain or swelling at injection site | Very common |
| Headache | Common |
| Mild fever | Common |
| Dizziness | Common |
| Feeling sick or tired | Common |
More serious side effects, such as a severe allergic reaction, are very rare. Vaccination staff are trained to manage allergic reactions immediately if they occur.
Extensive research and ongoing monitoring show that the HPV vaccine is safe and effective.
The HPV vaccine is highly effective at preventing infections caused by the most harmful HPV types. In the UK, there has been a substantial reduction in cervical cancer and genital warts among vaccinated groups.
Research suggests that widespread HPV vaccination will prevent thousands of cancer cases and save many lives over time.
Even if you have received the HPV vaccine, attending cervical screening appointments remains essential. The vaccine does not protect against all HPV types that can cause cervical cancer.
Cervical screening helps detect abnormal cell changes early, allowing treatment before cancer develops.
The HPV vaccine is a major public health success. By preventing infection before it occurs, it reduces cancer risk, lowers healthcare costs, and improves quality of life.
High vaccination rates also reduce the spread of HPV across the population, offering indirect protection to others.
NHS HPV vaccine guidance.
This blog is intended for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for guidance about vaccinations or medical conditions.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.